AGMT
  • Die AGMT
    • Über uns
    • Vorstand
    • Team
    • Partner
    • Karriere
    • Kontakt
  • Studien
    • Hodgkin Lymphom
      • HD21
      • AERN
    • Non-Hodgkin Lymphom
      • NHL-15B
      • DSHNHL_NIVEAU
      • ORACLE
    • Multiples Myelom
      • MM-2
      • MM-3
      • DSMM_XVII
    • Mammakarzinom
      • MBC-10
    • Kolorektalkarzinom
      • SAKK 41/14 Active-2
    • Pankreaskarzinom
      • DIsCOvER
    • COVID-19
      • INSERM_DisCoVeRy
  • Register
    • AIHA Registry
    • ALL Register
    • aMYELOIDr
    • BV NIS
    • HMA Register
    • MBC Register
    • NGS Register
    • PTCL Register
    • LungCA Register
    • COVID-19 Register
  • Veranstaltungen
    • AGMT Jahresmeeting
    • Breast Cancer Talk
    • GI Cancer Summit
  • Publikationen
  • News
    • News Übersicht
    • Newsletter
    • Presseaussendungen
    • News Archiv
  • Kontakt
  • AAA
  • Login
  • de
    Languages
    • en English
    • de Deutsch
Breast Cancer Talk 2020

Salzburg Breast Cancer Talk

BREAKING NEWS:

Due to the ongoing situation regarding the coronavirus epidemic we have to cancel the 4th Salzburg Breast Cancer Talk 2020, because an event with so many speakers from abroad (Italy, UK, Canada) in October still poses too high a risk and we do not want to implement a virtual solution here.
The event is planned again for 2021 with an identical program.

Further information will follow…

In order of appearanceThe Faculty

Prof. Dr. Richard Greil
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Simon P. Gampenrieder
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Gabriel Rinnerthaler
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Luca Gianni MD
Michelangelo Foundation, Milan, Italy
Dr. Iosifina Foskolou
Prof. R. Johnson’s Group, Evelyn Trust Patrick Sissons Fellow, Darwin College, Cambridge, United Kingdom; Jonas Söderquists Scholar, Karolinska Institutet, Stockholm, Sweden
Prof. Pedro Romero MD
Associate Director, Department of Fundamental Oncology, Lausanne University Hospital (CHUV), Faculty of Biology and Medicine, University of Lausanne, Switzerland
Berna Özdemir MD PhD
Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland
Onur Boyman MD
Professor and Chair of Clinical Immunology, Deputy Dean of Faculty of Medicine, University of Zurich; Director, Department of Immunology, University Hospital Zurich, Switzerland
Prof. Alberto Mantovani MD
Humanitas University, Scientific Director, Istituto Clinico Humanitas IRCCS Milan, Italy
William Harvey Research Institute, London
Marie-Agnès Doucey PhD MER
University of Lausanne and Director & Project Team Leader – Discovery, Ichnos Sciences SA, Lausanne, Switzerland
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Karen Willard-Gallo MD PhD
Head, Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Prof. Dr. Barbara Seliger
Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Giuseppe Curigliano MD PhD
University of Milan, Director, New Drugs and Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy
Marco Gerlinger MD FRCP
Medical Oncologist and Research Group Leader, Translational Oncogenomics Laboratory, Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom
Dr. Laszlo G. Radvanyi PhD
President and Scientific Director, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
Dr. John Maher
Consultant and Senior Lecturer in Immunology, King’s College London, United Kingdom

Program

Friday, 23. October 2020

12:30 – 13:30 Welcome & Business Lunch


13:30 – 13:35 Introduction
Richard Greil, Salzburg


13:35 – 14:25 The clinical point of view
Oxford-style debate: Immunotherapy in breast cancer: failure or magic bullet?
Simon Gampenrieder – pro/ Gabriel Rinnerthaler – contra (Salzburg)
Predictive biomarkers in breast cancer immunotherapy trials
Luca Gianni (Milan)


14:25 – 15:15 Metabolism and metabolomics
Hypoxia-inducible metabolites shape T cell fate
Iosifina Foskolou (Cambridge)
Navigating metabolic pathways to enhance antitumor immunity and immunotherapy
Pedro Romero (Lausanne)


15:15 – 15:45 Coffee break


15:45 – 16:35 Influence on immunogenicity
… by sex hormones
Berna C. Özdemir (Lausanne)
… epigenetic regulation
Onur Boyman (Zurich)
16:35 – 17:30 The innate immune system
Innate Immunity , inflammation and cancer: double edged swords
Alberto Mantovani (Milan)
Pharmacological re-programming of CD144 pro-metastatic monocytes in human breast cancer
Marie-Agnes Doucey (Lausanne)

17:30 – 18:30 Panel discussion


19:00 Dinner


Saturday, 24. October 2020

08:30 – 10:00 The adaptive immune system
PD-L1 vs. TILs: analytic and diagnostic issues
Roberto Salgado (Antwerp)
Tertiary lymphoid structures: Phenotypic, genotypic and functional features and their link with the response to cancer immunotherapy
Karen Willard-Gallo (Brussels)
MHC class I loss in breast cancer
Barbara Seliger (Halle)


10:00 – 10:30 Coffee break


10:30 – 12:10 New treatment strategies
Immunotherapy strategies beyond PD1/PD-L1 inhibition
Giuseppe Curigliano (Milan)
Bispecific antibodies in the treatment of solid tumors
Marco Gerlinger (London)
Adoptive T cell therapy for metastatic melanoma: Lessons learned and implications for breast cancer
Laszlo G. Radvanyi (Toronto)
CAR T-Cells in breast cancer
John Maher (London)
12:10 – 12:55 Panel discussion
Closing Remarks
Richard Greil (Salzburg)


13:00 – 14:00 Business Lunch & Farewell


Registration

We look forward to your registration, but we would like to point out that this conference is not open to the public. After your registration your entries will be checked by us, followed by information about your requested participation.

Accreditation by EACCME®

4th SALZBURG BREAST CANCER TALK – Mastering translational Immuno-Oncology has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 8 European CME credits (ECMEC®s).

Venue

Organisation

Prof. Dr. Richard Greil
Dr. Simon P. Gampenrieder
Dr. Gabriel Rinnerthaler

AGMT gemeinnützige GmbH

Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR)

Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT)

in Kooperation mit
Cancer Cluster Salzburg | www.cancercluster-salzburg.at

Photos

Gruppenfoto

Salzburg Breast Cancer Talk 2019

G. Rinnerthaler, C. Quadt, MA Doucey, C. Pozzi, MV Dieci, C. Garlanda, R. Salgado, K. Willard-Gallo, R. Greil, R. Derloo, M. Jalving, RD Kennedy, SP Gampenrieder
Richard Greil

Salzburg Breast Cancer Talk 2019

Richard Greil
Richard Greil

Salzburg Breast Cancer Talk 2019

Richard Greil
Regula Derloo

Salzburg Breast Cancer Talk 2019

Regula Derloo decided to stand in for Peter Schmid at short notice. Thanks again!
Regula Derloo

Salzburg Breast Cancer Talk 2019

Regula Derloo
Regula Derloo

Salzburg Breast Cancer Talk 2019

Regula Derloo
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Karen Willard-Gallo

Salzburg Breast Cancer Talk 2019

Karen Willard-Gallo
Karen Willard-Gallo

Salzburg Breast Cancer Talk 2019

Karen Willard-Gallo
Karen Willard-Gallo

Salzburg Breast Cancer Talk 2019

Karen Willard-Gallo
Roberto Salgado

Salzburg Breast Cancer Talk 2019

Roberto Salgado
Roberto Salgado

Salzburg Breast Cancer Talk 2019

Roberto Salgado
Roberto Salgado

Salzburg Breast Cancer Talk 2019

Roberto Salgado
Marie-Agnès Doucey

Salzburg Breast Cancer Talk 2019

Marie-Agnès Doucey
Marie-Agnès Doucey

Salzburg Breast Cancer Talk 2019

Marie-Agnès Doucey
Marie-Agnès Doucey

Salzburg Breast Cancer Talk 2019

Marie-Agnès Doucey
Cecilia Garlanda

Salzburg Breast Cancer Talk 2019

Cecilia Garlanda
Panel discussion

Salzburg Breast Cancer Talk 2019

Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Panel discussion

Salzburg Breast Cancer Talk 2019

Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Panel discussion

Salzburg Breast Cancer Talk 2019

Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Audience at Salzburg Breast Cancer Talk 2019
Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Salzburg Breast Cancer Talk 2019

Photos: Franz Neumayr

Video

News

26Feb
4th SALZBURG BREAST CANCER TALK

POSTPONED DUE TO SARS-CoV-2 Due to the current situation concerning the coronavirus epidemic and the resulting travel restrictions of even already planned speakers, we have decided to reschedule our event „Salzburg Breast Cancer Talk“ to 2021....

18Mrz
3rd SALZBURG BREAST CANCER TALK 2019 wieder voller Erfolg!

Die Veranstaltung 3rd SALZBURG BREAST CANCER TALK, MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY vom 01. bis 02.03.2019, im PITTER Event Center Salzburg war mit über 100 Teilnehmern wieder ein voller Erfolg. Die Vortragenden, alle auf ihrem Fachgebiet international renommierte Wissenschaftler, verstanden es eindrucksvoll, dem fachkundigen Publikum Einblicke in ihre Forschung am Puls der Zeit zu gewähren. Die Disskusionsrunden […]...

16Nov
3rd SALZBURG BREAST CANCER TALK

01.- 02.03.2019  Salzburg   —   MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY...

Breast Cancer Talk
  • Veranstaltungen
    • Breast Cancer Talk – 2020
    • Program
    • Accreditation
    • Venue
    • Organisation
  • Past Events
    • Breast Cancer Talk – 2019
    • Breast Cancer Talk – 2018
    • News Archive
Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH
Firmensitz und Rechnungsadresse: Gentzgasse 60/21, 1180 Wien
Zweigstelle & Zustelladresse: Wolfsgartenweg 31, 5020 Salzburg
Firmenbuchnummer: FN 289548 g
UID-Nummer: ATU63467108
+43 662 640 44 12
+ 43 664 142 25 04
+43 662 640 44 14
office@agmt.at
Copyright © AGMT gemeinnützige GmbH
  • Impressum
  • Datenschutzerklärung
Wir verwenden Cookies, um Ihr Erlebnis auf unserer Website so angenehm wie möglich zu gestalten, um Inhalte und Anzeigen zu personalisieren, Funktionen für soziale Medien anbieten zu können und die Zugriffe auf unsere Website zu analysieren. Außerdem geben wir Informationen zu Ihrer Verwendung unserer Website an unsere Partner für soziale Medien, Werbung und Analysen weiter. Unsere Partner führen diese Informationen möglicherweise mit weiteren Daten zusammen, die Sie ihnen bereitgestellt haben oder die sie im Rahmen Ihrer Nutzung der Dienste gesammelt haben. Mit der weiteren Nutzung der Seite geben Sie die Einwilligung zu unseren Cookies. Weitere Informationen über unsere Datenerfassungspraktiken finden Sie in unserer Datenschutzerklärung.OK